Cargando…
Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity
Whether high blood eosinophil counts may define a better phenotype in bronchiectasis patients, as shown in chronic obstructive pulmonary disease (COPD), remains to be investigated. Differential phenotypic characteristics according to eosinophil counts were assessed using a biostatistical approach in...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392197/ https://www.ncbi.nlm.nih.gov/pubmed/34444179 http://dx.doi.org/10.3390/ijerph18168431 |
_version_ | 1783743444774027264 |
---|---|
author | Wang, Xuejie Villa, Carmen Dobarganes, Yadira Olveira, Casilda Girón, Rosa García-Clemente, Marta Máiz, Luis Sibila, Oriol Golpe, Rafael Menéndez, Rosario Rodríguez-López, Juan Prados, Concepción Martinez-García, Miguel Angel Rodriguez, Juan Luis de la Rosa, David Duran, Xavier Garcia-Ojalvo, Jordi Barreiro, Esther |
author_facet | Wang, Xuejie Villa, Carmen Dobarganes, Yadira Olveira, Casilda Girón, Rosa García-Clemente, Marta Máiz, Luis Sibila, Oriol Golpe, Rafael Menéndez, Rosario Rodríguez-López, Juan Prados, Concepción Martinez-García, Miguel Angel Rodriguez, Juan Luis de la Rosa, David Duran, Xavier Garcia-Ojalvo, Jordi Barreiro, Esther |
author_sort | Wang, Xuejie |
collection | PubMed |
description | Whether high blood eosinophil counts may define a better phenotype in bronchiectasis patients, as shown in chronic obstructive pulmonary disease (COPD), remains to be investigated. Differential phenotypic characteristics according to eosinophil counts were assessed using a biostatistical approach in a large cohort study from the Spanish Online Bronchiectasis Registry (RIBRON). The 906 patients who met the inclusion criteria were clustered into two groups on the basis of their eosinophil levels. The potential differences according to the bronchiectasis severity index (BSI) score between two groups (Mann–Whitney U test and eosinophil count threshold: 100 cells/µL) showed the most balanced cluster sizes: above-threshold and below-threshold groups. Patients above the threshold exhibited significantly better clinical outcomes, lung function, and nutritional status, while showing lower systemic inflammation levels. The proportion of patients with mild disease was higher in the above-threshold group, while the below-threshold patients were more severe. Two distinct clinical phenotypes of stable patients with non-cystic fibrosis (CF) bronchiectasis of a wide range of disease severity were established on the basis of blood eosinophil counts using a biostatistical approach. Patients classified within the above-threshold cluster were those exhibiting a mild disease, significantly better clinical outcomes, lung function, and nutritional status while showing lower systemic inflammatory levels. These results will contribute to better characterizing bronchiectasis patients into phenotypic profiles with their clinical implications. |
format | Online Article Text |
id | pubmed-8392197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83921972021-08-28 Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity Wang, Xuejie Villa, Carmen Dobarganes, Yadira Olveira, Casilda Girón, Rosa García-Clemente, Marta Máiz, Luis Sibila, Oriol Golpe, Rafael Menéndez, Rosario Rodríguez-López, Juan Prados, Concepción Martinez-García, Miguel Angel Rodriguez, Juan Luis de la Rosa, David Duran, Xavier Garcia-Ojalvo, Jordi Barreiro, Esther Int J Environ Res Public Health Article Whether high blood eosinophil counts may define a better phenotype in bronchiectasis patients, as shown in chronic obstructive pulmonary disease (COPD), remains to be investigated. Differential phenotypic characteristics according to eosinophil counts were assessed using a biostatistical approach in a large cohort study from the Spanish Online Bronchiectasis Registry (RIBRON). The 906 patients who met the inclusion criteria were clustered into two groups on the basis of their eosinophil levels. The potential differences according to the bronchiectasis severity index (BSI) score between two groups (Mann–Whitney U test and eosinophil count threshold: 100 cells/µL) showed the most balanced cluster sizes: above-threshold and below-threshold groups. Patients above the threshold exhibited significantly better clinical outcomes, lung function, and nutritional status, while showing lower systemic inflammation levels. The proportion of patients with mild disease was higher in the above-threshold group, while the below-threshold patients were more severe. Two distinct clinical phenotypes of stable patients with non-cystic fibrosis (CF) bronchiectasis of a wide range of disease severity were established on the basis of blood eosinophil counts using a biostatistical approach. Patients classified within the above-threshold cluster were those exhibiting a mild disease, significantly better clinical outcomes, lung function, and nutritional status while showing lower systemic inflammatory levels. These results will contribute to better characterizing bronchiectasis patients into phenotypic profiles with their clinical implications. MDPI 2021-08-10 /pmc/articles/PMC8392197/ /pubmed/34444179 http://dx.doi.org/10.3390/ijerph18168431 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wang, Xuejie Villa, Carmen Dobarganes, Yadira Olveira, Casilda Girón, Rosa García-Clemente, Marta Máiz, Luis Sibila, Oriol Golpe, Rafael Menéndez, Rosario Rodríguez-López, Juan Prados, Concepción Martinez-García, Miguel Angel Rodriguez, Juan Luis de la Rosa, David Duran, Xavier Garcia-Ojalvo, Jordi Barreiro, Esther Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity |
title | Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity |
title_full | Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity |
title_fullStr | Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity |
title_full_unstemmed | Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity |
title_short | Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity |
title_sort | phenotypic clustering in non-cystic fibrosis bronchiectasis patients: the role of eosinophils in disease severity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392197/ https://www.ncbi.nlm.nih.gov/pubmed/34444179 http://dx.doi.org/10.3390/ijerph18168431 |
work_keys_str_mv | AT wangxuejie phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT villacarmen phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT dobarganesyadira phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT olveiracasilda phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT gironrosa phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT garciaclementemarta phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT maizluis phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT sibilaoriol phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT golperafael phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT menendezrosario phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT rodriguezlopezjuan phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT pradosconcepcion phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT martinezgarciamiguelangel phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT rodriguezjuanluis phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT delarosadavid phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT duranxavier phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT garciaojalvojordi phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity AT barreiroesther phenotypicclusteringinnoncysticfibrosisbronchiectasispatientstheroleofeosinophilsindiseaseseverity |